BioNexus Gene Lab Corp (Nasdaq:BGLC)
N/A • N/A
CIK 1737523
Company
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.
Address
N/A
N/A
Employees
None
None
Stock Info
Key Executives
Board Of Directors
SEC filings
Date | Form | Event |
---|---|---|
15 Nov, 2024 | 10-Q | |
14 Nov, 2024 | NT 10-Q | |
8 Nov, 2024 | 8-K | |
15 Oct, 2024 | 8-K | |
10 Oct, 2024 | 8-K | |
25 Sep, 2024 | 8-K | |
18 Sep, 2024 | 8-K | |
16 Sep, 2024 | DEF 14A | |
12 Sep, 2024 | 8-K | |
6 Sep, 2024 | PRE 14A | |
5 Sep, 2024 | 8-K | |
28 Aug, 2024 | 8-K | |
26 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
5 Jul, 2024 | 8-K/A | |
6 Jun, 2024 | UPLOAD | |
31 May, 2024 | 10-K/A | |
31 May, 2024 | 10-Q/A | |
31 May, 2024 | 10-Q/A | |
31 May, 2024 | 10-Q/A | |
31 May, 2024 | 10-K/A | |
23 May, 2024 | CORRESP | |
15 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
6 May, 2024 | UPLOAD | |
18 Apr, 2024 | 8-K | |
16 Apr, 2024 | 10-K | |
1 Apr, 2024 | 8-K | |
28 Mar, 2024 | NT 10-K | |
26 Mar, 2024 | 10-Q/A | |
29 Feb, 2024 | DEF 14C | |
26 Jan, 2024 | PRE 14C | |
23 Jan, 2024 | SC 13G | |
17 Jan, 2024 | SC 13D | |
20 Nov, 2023 | 10-Q | |
14 Nov, 2023 | NT 10-Q | |
13 Nov, 2023 | 8-K | |
3 Nov, 2023 | 8-K | |
30 Oct, 2023 | 8-K/A | |
17 Oct, 2023 | SC 13G | |
16 Oct, 2023 | 8-K | CEO Change |
11 Oct, 2023 | 8-K | CEO Change |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
4 Oct, 2023 | 3 | |
7 Sep, 2023 | 8-K | |
16 Aug, 2023 | 10-Q | |
14 Aug, 2023 | NT 10-Q | |
24 Jul, 2023 | 8-K | |
21 Jul, 2023 | 424B4 | |
20 Jul, 2023 | CERT | |
20 Jul, 2023 | 8-K | |
19 Jul, 2023 | 8-A12B | |
19 Jul, 2023 | EFFECT | |
17 Jul, 2023 | S-1/A | |
5 Jul, 2023 | S-1/A | |
17 May, 2023 | DEF 14C | |
9 May, 2023 | 10-Q | |
9 May, 2023 | S-1/A | |
31 Mar, 2023 | 10-K | |
10 Mar, 2023 | DEFR14C | |
21 Feb, 2023 | DEF 14C | |
14 Feb, 2023 | S-1 | |
10 Feb, 2023 | PRE 14C | |
14 Nov, 2022 | 10-Q | |
15 Aug, 2022 | 10-Q | |
15 Aug, 2022 | 8-K | CEO Change |
16 May, 2022 | 10-Q | |
6 Apr, 2022 | 10-K | |
1 Apr, 2022 | NT 10-K | |
15 Nov, 2021 | 10-Q | |
12 Aug, 2021 | 10-Q | |
18 May, 2021 | 10-Q | |
17 May, 2021 | NT 10-Q | |
30 Mar, 2021 | 10-K | |
11 Mar, 2021 | 8-K/A | |
7 Jan, 2021 | 8-K |
Last update:2025-03-06 12:46:13.130128
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.